Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 1/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 4/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 4/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 4/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21971955 | 0.87 | NCF1 (0.34) | NCF1GNAI3GNAO1GNAI1 | |
| SCHEMBL22292525 | 0.84 | GNAO1 (0.40) | NCF1GNAI3GNAO1GNAI1 | |
| SCHEMBL16260084 | 0.82 | NCF1 (0.37) | NCF1GNAI3GNAO1GNAI1 | |
| SCHEMBL18799818 | 0.81 | GNAO1 (0.45) | NCF1GNAI3GNAO1GNAI1 | |
| SCHEMBL17327871 | 0.81 | NCF1 (0.39) | NCF1GNAI3GNAO1GNAI1ACHE | |
| SCHEMBL12536135 | 0.79 | NCF1 (0.38) | NCF1GNAI3GNAO1GNAI1 | |
| SCHEMBL25038693 | 0.79 | GNAO1 (0.42) | NCF1GNAI3GNAO1GNAI1 | |
| SCHEMBL22004465 | 0.76 | GNAO1 (0.47) | NCF1GNAI3GNAO1GNAI1 | |
| SCHEMBL25004891 | 0.74 | GNAO1 (0.46) | NCF1GNAI3GNAO1GNAI1 | |
| SCHEMBL18672421 | 0.74 | GNAO1 (0.46) | NCF1GNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230075221-A1 | SUBSTITUTED 1,2,4-TRIAZOLO[4,3-A]PYRIDINE DERIVATIVE AND PREPARATION METHOD, HERBICIDAL COMPOSITION AND APPLICATION THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230075221-A1 | SUBSTITUTED 1,2,4-TRIAZOLO[4,3-A]PYRIDINE DERIVATIVE AND PREPARATION METHOD, HERBICIDAL COMPOSITION AND APPLICATION THEREOF | TH, CYP4X1, CYP4B1 | NCF1 2939/4885GNAI3 2018/4885GNAO1 1222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.